Lymphocyte to C-reactive protein ratio predicts long-term outcomes for patients with lower rectal cancer.
Masaaki NishiMistuo ShimadaTakuya TokunagaJun HigashijimaKozo YoshikawaHideya KashiharaChie TakasuDaichi IshikawaYuma WadaShohei EtoToshiaki YoshimotoPublished in: World journal of surgical oncology (2021)
Post-CRT LCR could be a prognostic biomarker for patients with lower rectal cancer.